Bifidobacteria can potentially be used for gene therapy. Here, we reported that 65% of the total hIFN-alpha2b produced from Bifidobacteria longum transformed with pBAD-SPIFN plasmids encoding a fusion protein of the arabinosidase signal peptide and human IFN-alpha2b (hIFN-alpha2b), was secreted. For B. longum transformed with pBAD-IFN plasmids (hIFN-alpha2b without the signal peptide), only 15% of the total IFN-alpha2b was secreted and western blotting and N-terminal amino-acid sequence analysis revealed cleavage of the arabinosidase signal peptide from the secreted hIFN-alpha2b. Moreover, the active level of the secreted hIFN-alpha2b in the supernatant of B. longum transformed with pBAD-SPIFN plasmids was over 1,000 IU/ml commercial rhIFN-alpha2b. Hence, the arabinosidase signal peptide can enhance the secretion efficiency of IFN-alpha2b from B. longum.